Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.5300
+0.0397 (8.10%)
At close: Apr 7, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $940.69 thousand as of April 8, 2026. Its market cap has decreased by -91.84% in one year.
Market Cap
940.69K
Enterprise Value
15.31M
Revenue
398.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.53
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 940.69K, a decrease of -99.59%. That is a compound annual growth rate of -60.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 940.69K | -82.79% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scorpius Holdings | 1.22M |
| Avenue Therapeutics | 1.15M |
| Evofem Biosciences | 1.10M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.05M |
| Protagenic Therapeutics | 959.41K |
| THC Farmaceuticals | 805.04K |
| Halberd | 780.93K |